Results 271 to 280 of about 94,483 (313)

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Nature Medicine, 2022
, Darin K Edwards, Rolando Pajon
exaly  

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Nature Communications, 2020
Timothy P Sheahan, Sarah R Leist, Alexandra Schäfer   +2 more
exaly  

In Vitro Study of beta-Adrenergic Receptors

Annual Review of Pharmacology and Toxicology, 1977
B B, Wolfe, T K, Harden, P B, Molinoff
openaire   +2 more sources

Autoantibodies to beta-adrenergic receptors and asthma

Journal of Allergy and Clinical Immunology, 1984
C M, Fraser, J C, Venter
openaire   +2 more sources

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly  

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma

Signal Transduction and Targeted Therapy, 2021
Liang Chen, You-Chun Wang, Chuan Qin
exaly  

Double beta decay, Majorana neutrinos, and neutrino mass

Reviews of Modern Physics, 2008
Jonathan Engel
exaly  

Beta-Adrenergic Receptor Blocking Drugs

Medical Clinics of North America, 1973
T, Lawrence, W S, Frankl
openaire   +2 more sources

Verapamil and beta cell function in adults with recent-onset type 1 diabetes

Nature Medicine, 2018
Fernando Ovalle, Guanlan Xu, Peng Li
exaly  

Reconstitution of the β-adrenergic receptor

The Journal of Membrane Biology, 1985
R J, Lefkowitz, R A, Cerione, J, Codina, L, Birnbaumer, M G, Caron   +4 more
openaire   +2 more sources